Syndax Pharmaceuticals, Inc.
(NASDAQ : SNDX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -3.96%58.190.0%$1899.37m
REGNRegeneron Pharmaceuticals, Inc. -0.26%597.002.5%$1174.48m
GILDGilead Sciences, Inc. -1.02%76.751.0%$975.82m
AMGNAmgen, Inc. 2.17%225.671.3%$660.44m
NVAXNovavax, Inc. 3.67%46.30102.0%$655.72m
VRTXVertex Pharmaceuticals, Inc. -2.61%265.691.9%$544.78m
ILMNIllumina, Inc. -1.20%354.113.5%$388.06m
BIIBBiogen, Inc. 2.36%306.721.6%$378.26m
SRNESorrento Therapeutics, Inc. 6.74%4.121.8%$269.11m
ALXNAlexion Pharmaceuticals, Inc. 1.35%115.212.0%$241.70m
SGENSeattle Genetics, Inc. -1.36%148.396.1%$223.95m
AAgilent Technologies, Inc. -0.83%90.381.6%$215.81m
BMRNBioMarin Pharmaceutical, Inc. -1.59%105.804.3%$184.97m
SRPTSarepta Therapeutics, Inc. 2.06%147.9913.9%$156.63m
INCYIncyte Corp. -0.31%93.512.5%$153.41m

Company Profile

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include candidate and entinostat. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.